Stay updated on IMM60 and Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the IMM60 and Pembrolizumab Clinical Trial page.
Latest updates to the IMM60 and Pembrolizumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe Record History adds revision v3.3.2 and removes v3.2.0 in the version list.SummaryDifference0.1%
- Check28 days agoChange DetectedRemoved the government funding/operating status notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%
- Check43 days agoChange DetectedThe history shows multiple updates to study status and recruitment status across several versions. These changes reflect ongoing updates to the trial's progress and enrollment.SummaryDifference0.1%
- Check71 days agoChange DetectedUpdate announces version v3.2.0 and adds a government funding status notice with operating details; removes the previous v3.1.0 tag. The core page now communicates current operating status and a higher-level version indicator.SummaryDifference12%
- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%
- Check93 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No changes to pricing, stock, or time-slot data.SummaryDifference0.7%
Stay in the know with updates to IMM60 and Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM60 and Pembrolizumab Clinical Trial page.